Skip to main content
. 2024 Jan 16;12:1296939. doi: 10.3389/fpubh.2024.1296939

Table 2.

Consistency between self-reported disease diagnosis and clinical assessment.

Diseases Self-report diagnosis Clinical assessment Agreement (95% CI), % Sensitivity (95% CI), % Specificity (95% CI), % Under-reporting (95% CI), % Over-reporting (95% CI), %
+
Goiter + 5 19 97.74 (97.45, 98.03) 14.07 (13.38, 14.75) 99.12 (98.93, 99.30) 85.93 (85.25, 86.62) 0.88 (0.70, 1.07)
31 2,217
Hyperuricemia + 54 76 83.55 (82.82, 84.28) 16.06 (15.34, 16.78) 95.93 (95.54, 96.31) 83.94 (83.22, 84.66) 4.07 (3.69, 4.46)
294 1,848
Thyroid nodules + 65 45 89.81 (89.21, 90.40) 27.11 (26.24, 27.98) 97.68 (97.38, 97.97) 72.89 (72.02, 73.76) 2.32 (2.03, 2.62)
181 1,981
Hyperlipidemia + 359 490 62.13 (61.18, 63.08) 49.84 (48.86, 50.82) 67.89 (66.98, 68.81) 50.16 (49.18, 51.14) 32.11 (31.19, 33.02)
373 1,050
Diabetes + 166 0 92.92 (92.41, 93.42) 50.92 (49.94, 51.90) 100.00 (99.82, 100.00) 49.08 (48.10, 50.06) 0.00 (0.00, 0.18)
163 1,943
Hypertension + 370 0 90.30 (89.72, 90.88) 62.57 (61.62, 63.52) 100.00 (99.79, 100.00) 37.43 (36.48, 38.38) 0.00 (0.00, 0.21)
222 1,680
Hypothyroidism + 33 38 97.57 (97.26, 97.87) 68.43 (67.51, 69.34) 98.23 (97.97, 98.49) 31.57 (30.66, 32.49) 1.77 (1.51, 2.03)
16 2,185
Hyperthyroidism + 28 12 99.24 (99.06, 99.41) 84.88 (84.18, 85.58) 99.45 (99.31, 99.60) 15.12 (14.42, 15.82) 0.55 (0.40, 0.69)
5 2,227

+, positive; −, negative; CI, confidence interval.